How Much Does Rapamycin (Sirolimus) Cost in Utah in 2026?

Utah Retail Pharmacy Pricing for Sirolimus in 2026

The average cash-pay price for generic sirolimus at Utah retail pharmacies sits at roughly $80 per month in 2026. That figure reflects a 30-day supply of 1 mg tablets, the most commonly dispensed strength. Branded Rapamune from Pfizer carries a wholesale acquisition cost near $600 per month, but the generic market has compressed actual out-of-pocket spending dramatically since sirolimus lost patent exclusivity.

Pricing varies by pharmacy. Large chains like Walgreens and CVS locations in Salt Lake City, Provo, and Ogden tend to price generics within a few dollars of each other. Independent pharmacies sometimes beat chain pricing by 10 to 15 percent, especially for cash-pay patients who negotiate directly. The real differentiator is whether you use a discount card. Platforms like GoodRx, RxSaver, and SingleCare routinely list 30-day generic sirolimus supplies between $55 and $90 at Utah locations, depending on the pharmacy and the specific manufacturer (FDA-approved sirolimus labeling and pricing data).

For patients using sirolimus off-label at once-weekly dosing (typically 3 to 6 mg per week), a single 30-tablet bottle of 1 mg tablets can last several months. This changes the effective monthly cost considerably. Four tablets per month at a $80 per 30-tablet supply works out to roughly $10 to $12 per month. That math matters.

Compounded Sirolimus: Legal, Available, and Priced Differently

Compounded sirolimus is legal in Utah through licensed 503A pharmacies. These pharmacies operate under federal and state law to prepare patient-specific prescriptions when a prescriber determines a clinical need, such as a dose or formulation not commercially available (FDA guidance on 503A compounding).

The average cost for compounded sirolimus in Utah runs about $120 per month. That premium over generic tablets reflects the labor-intensive nature of compounding, smaller batch sizes, and quality-testing requirements. Some patients choose compounded formulations because they want a specific dose (say, 5 mg capsules for weekly use) rather than splitting or combining commercial tablets. Others prefer topical rapamycin formulations for dermatologic applications, which are only available through compounding.

Utah's Board of Pharmacy oversees 503A facilities operating within the state. Out-of-state 503A pharmacies can also ship to Utah patients provided they hold appropriate licenses. Before ordering compounded sirolimus, verify that the pharmacy is registered with both the Utah Division of Occupational and Professional Licensing (DOPL) and complies with USP 795/800 standards. Not every compounding pharmacy stocks sirolimus; call ahead.

A few points worth knowing: compounded drugs are not FDA-approved products, and insurance plans almost never cover them. The $120 per month figure is a true out-of-pocket cost for most patients. Some longevity clinics bundle compounded sirolimus into membership fees, which can change the per-month math depending on what else the membership includes.

Utah Medicaid and Sirolimus Coverage

Utah Medicaid does not cover sirolimus for off-label longevity or anti-aging use. This is consistent with most state Medicaid programs, which restrict sirolimus coverage to its FDA-approved indications: prevention of organ transplant rejection (renal) and treatment of lymphangioleiomyomatosis (LAM) (FDA-approved sirolimus prescribing information).

For transplant patients enrolled in Utah Medicaid, sirolimus is generally accessible through prior authorization. The state's preferred drug list includes generic sirolimus as a covered immunosuppressant, subject to clinical criteria such as documented transplant status, prescriber specialty verification, and trough-level monitoring. Approval typically requires the prescribing transplant center to submit supporting documentation.

The gap between FDA-labeled use and the growing off-label longevity market creates real confusion for patients. If your physician writes a sirolimus prescription for "anti-aging" or "geroprotection," expect Medicaid to deny the claim. Even if the prescription lists a covered diagnosis code, utilization management algorithms flag dose patterns (once-weekly) that do not match transplant protocols (daily). This is a practical barrier that no discount card can bypass for Medicaid enrollees seeking off-label access.

Commercial Insurance Coverage in Utah

Commercial insurance plans in Utah, including those offered through Regence BlueCross BlueShield of Utah, SelectHealth, Molina, and University of Utah Health Plans, generally cover sirolimus for FDA-approved transplant indications. Coverage for off-label use varies. Most plans do not cover longevity-focused prescriptions, though some may cover off-label use if supported by compendia citations or peer-reviewed evidence.

Prior authorization is standard. Expect the insurer to require documentation of the specific indication, confirmation that the patient has tried or cannot use alternative agents, and ongoing lab monitoring. For transplant patients, approval is usually straightforward. For off-label applications, the denial rate is high.

Copay amounts under commercial plans range from $10 to $50 per month for generic sirolimus on a preferred formulary tier. If the plan places sirolimus on a specialty tier (less common for generics, but it happens), copays can reach $100 to $200. Always check your plan's formulary before assuming coverage. A study examining immunosuppressant access barriers found that formulary tier placement significantly affects medication adherence in transplant populations (Muduma et al., 2016).

Manufacturer Savings Programs and Discount Cards

Pfizer offers a savings card for branded Rapamune that can reduce copays for commercially insured patients. The program typically caps out-of-pocket costs at $0 to $25 per month for eligible patients, though government-insured individuals (Medicare, Medicaid, Tricare) are excluded by federal anti-kickback rules. Check Pfizer's patient assistance portal for current terms.

For generic sirolimus, savings cards from GoodRx, RxSaver, and SingleCare are the most accessible cost-reduction tools in Utah. These cards are free, accepted at virtually all chain pharmacies, and require no insurance. Prices fluctuate weekly, so comparing across platforms before each refill can save $10 to $30. One pattern worth noting: Costco pharmacies (you do not need a Costco membership to use the pharmacy in most states, including Utah) frequently offer the lowest generic sirolimus pricing in the Salt Lake metro area.

Patient assistance programs (PAPs) from generic manufacturers exist but are less well-publicized than Pfizer's Rapamune program. NeedyMeds and RxAssist maintain searchable databases of active PAPs. Income eligibility thresholds vary, but most require household income below 300 to 400 percent of the federal poverty level.

Telehealth Access to Sirolimus in Utah

Utah permits telehealth prescribing of sirolimus. The state's telehealth parity laws, updated in recent legislative sessions, allow physicians and advanced practice providers to prescribe Schedule VI and non-scheduled medications via audio-video consultations without requiring an in-person visit first (Utah Code 26-60, Telehealth Act).

Several national telehealth platforms now offer rapamycin consultations for longevity-focused patients in Utah. These services typically charge a consultation fee ($99 to $250 for an initial visit) plus the cost of the medication itself. Some platforms partner with compounding pharmacies and bundle the medication into their pricing. Others write prescriptions to retail pharmacies, leaving the patient to fill at their preferred location.

The PEARL trial (Participatory Evaluation of Aging with Rapamycin for Longevity), published in Aging Cell in 2024, enrolled 150 healthy participants aged 50 to 85 and found that rapamycin 5 mg weekly for 12 months was well-tolerated, with no serious adverse events attributable to the drug and a modest but measurable improvement in several aging biomarkers (Kaeberlein et al., 2024). This trial has been cited by longevity clinicians as supporting evidence for the dose and schedule most commonly prescribed via telehealth. Dr. Matt Kaeberlein, the study's principal investigator, noted: "The safety profile at this dose and frequency is reassuring, though we need larger, longer trials before making population-level recommendations."

Before starting a telehealth rapamycin consultation, confirm that the provider is licensed in Utah, that they order baseline labs (CBC, lipid panel, metabolic panel, fasting glucose), and that they have a plan for ongoing monitoring. Sirolimus can raise triglycerides and impair glucose tolerance at higher doses, effects documented extensively in the transplant literature (Morrisett et al., 2002).

Off-Label Dosing vs. Transplant Dosing: Why Cost Differs

The cost conversation changes depending on why you take sirolimus. Transplant patients typically take 2 mg daily (after a 6 mg loading dose on day one), adjusted to maintain trough blood levels of 12 to 20 ng/mL in the early post-transplant period and 4 to 12 ng/mL during maintenance. That daily regimen consumes 60 tablets per month at the 1 mg strength, roughly $160 at cash-pay rates.

Off-label longevity dosing is radically different. Most protocols call for 3 to 6 mg once weekly, which uses only 3 to 6 tablets per month of the 1 mg formulation. At $80 for 30 tablets, weekly dosing drops the effective monthly spend to $8 to $16. Even at compounded prices ($120 per month for a fixed weekly-dose supply), the cost is manageable for most patients paying out of pocket.

This dosing distinction also explains why insurance coverage matters less for the longevity cohort. When your monthly medication cost is $10 to $15, the administrative burden of prior authorization and appeals may not be worth the effort. Many longevity patients in Utah simply pay cash and skip insurance altogether.

The mTOR inhibition profile also differs by schedule. Intermittent (weekly) dosing preferentially inhibits mTORC1 while allowing mTORC2 recovery between doses. Daily dosing suppresses both complexes, which drives many of the metabolic side effects seen in transplant patients. A 2014 analysis in Science demonstrated that rapamycin's immunosuppressive effects are primarily mediated through chronic mTORC2 inhibition, while the geroprotective benefits correlate with mTORC1 suppression (Lamming et al., 2012). This pharmacologic rationale underpins the once-weekly protocols now common in the longevity medicine community.

How to Get the Lowest Price in Utah: A Decision Sequence

Start with your dose and schedule. If your provider prescribes once-weekly sirolimus at 5 mg, you need roughly 20 tablets of 1 mg per month (or 5 tablets of the less common 2 mg formulation, if available). Calculate your actual monthly tablet count before comparing prices.

Next, check discount cards. Run your prescription through GoodRx, RxSaver, and the Costco pharmacy price checker. Compare at least three Utah pharmacies. Prices can differ by 40 percent for the identical generic product from the identical manufacturer.

If you prefer a compounded formulation (custom dose capsules, topical cream), contact a Utah-licensed 503A pharmacy directly. Ask for pricing on your specific formulation and quantity. Budget $120 per month as a baseline, but some pharmacies charge less for simple capsule formulations.

Consider whether your commercial insurance plan covers sirolimus for your indication. If you have a transplant diagnosis, use insurance. If your use is off-label, the cash-pay route is almost always faster and often cheaper than fighting a denial. The American Society of Transplantation's guidelines confirm that post-transplant immunosuppression, including sirolimus-based regimens, should be managed with therapeutic drug monitoring and consistent access (Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group, 2009).

Finally, if cost remains a barrier, ask your provider about patient assistance programs or contact HealthRX for a pricing consultation specific to your situation.

Monitoring Costs: The Hidden Line Item

Sirolimus requires periodic blood work regardless of indication. A sirolimus trough level costs $50 to $150 without insurance at most Utah labs. Quest Diagnostics and ARUP Laboratories (headquartered in Salt Lake City) both offer this test. ARUP, affiliated with the University of Utah, often provides competitive self-pay pricing for Utah residents.

Standard monitoring also includes a complete metabolic panel, fasting lipid panel, and CBC every 3 to 6 months. Budget $100 to $300 per year in lab costs if paying cash. Some telehealth longevity platforms include labs in their subscription fees. Others do not. Ask before you sign up.

Hyperlipidemia is the most common lab abnormality with sirolimus, reported in up to 45 percent of transplant patients on daily dosing (Morrisett et al., 2002). At once-weekly longevity doses, the PEARL trial reported no clinically significant lipid changes at 12 months (Kaeberlein et al., 2024). Monitoring still matters. Catching a triglyceride spike early allows dose adjustment before cardiovascular risk accumulates.

The Endocrine Society recommends lipid monitoring within 4 to 8 weeks of starting any mTOR inhibitor and at regular intervals thereafter (Endocrine Society Clinical Practice Guidelines). Your provider should be ordering these labs. If they are not, that is a red flag about the quality of your care.